Fulgent Genetics Inc (FLGT) Q3 2026 Earnings Call Highlights: Revenue Climbs 8% as Anatomic ...
Fulgent Genetics Inc (FLGT) posted $90.4 million in Q3 2026 revenue, narrowed its non-GAAP loss guidance on disciplined spending, and advanced its AI pathology and therapeutic development initiatives. Related Stocks: FLGT ,